Aging
Navigate
Submit an Article
Research Paper|Volume 12, Issue 20|pp. 20835–20861
SMARCD3 is a potential prognostic marker and therapeutic target in CAFs
Back to articleFigure 6(6 of 9)
100%
Figure 6
Figure 6.(A) IHC staining indicated that SMARCD3 was mainly expressed colon cancer associated fibroblasts. (B) SMARCD3 expression was most associated with fibroblasts by ssGSEA analysis.
Figure 6 — SMARCD3 is a potential prognostic marker and therapeutic target in CAFs | Aging